These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 28705644)
41. Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors - Lead series identification - Part II. Barberis C; Moorcroft N; Pribish J; Tserlin E; Gross A; Czekaj M; Barrague M; Erdman P; Majid T; Batchelor J; Levit M; Hebert A; Shen L; Moreno-Mazza S; Wang A Bioorg Med Chem Lett; 2017 Oct; 27(20):4735-4740. PubMed ID: 28927793 [TBL] [Abstract][Full Text] [Related]
42. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism. Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781 [TBL] [Abstract][Full Text] [Related]
43. The iron-regulatory hormone hepcidin: a possible therapeutic target? Rochette L; Gudjoncik A; Guenancia C; Zeller M; Cottin Y; Vergely C Pharmacol Ther; 2015 Feb; 146():35-52. PubMed ID: 25205158 [TBL] [Abstract][Full Text] [Related]
44. Functional analyses of recombinant mouse hepcidin-1 in cell culture and animal model. Yazdani Y; Keyhanvar N; Kalhor HR; Rezaei A Biotechnol Lett; 2013 Aug; 35(8):1191-7. PubMed ID: 23553521 [TBL] [Abstract][Full Text] [Related]
45. Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin. Latour C; Kautz L; Besson-Fournier C; Island ML; Canonne-Hergaux F; Loréal O; Ganz T; Coppin H; Roth MP Hepatology; 2014 Feb; 59(2):683-94. PubMed ID: 23907767 [TBL] [Abstract][Full Text] [Related]
46. PCB-77 disturbs iron homeostasis through regulating hepcidin gene expression. Wang L; Zhang S; Lin R; Li L; Zhang D; Li X; Liu S Gene; 2013 Dec; 532(1):146-51. PubMed ID: 24055725 [TBL] [Abstract][Full Text] [Related]
47. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease. Tandara L; Grubisic TZ; Ivan G; Jurisic Z; Tandara M; Gugo K; Mladinov S; Salamunic I Clin Biochem; 2015 Dec; 48(18):1252-7. PubMed ID: 26164540 [TBL] [Abstract][Full Text] [Related]
48. Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammation. Smith GF; Altman MD; Andresen B; Baker J; Brubaker JD; Chen H; Chen Y; Childers M; Donofrio A; Ferguson H; Fischer C; Fischmann TO; Gibeau C; Hicks A; Jin S; Kattar S; Kleinschek MA; Leccese E; Lesburg C; Li C; Lim J; Liu D; Maclean JKF; Mansoor F; Moy LY; Mulrooney EF; Necheva AS; Presland J; Rakhilina L; Yang R; Torres L; Zhang-Hoover J; Northrup A Bioorg Med Chem Lett; 2017 Jun; 27(12):2721-2726. PubMed ID: 28501511 [TBL] [Abstract][Full Text] [Related]
49. Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications. Vela D; Vela-Gaxha Z Exp Mol Med; 2018 Feb; 50(2):e436. PubMed ID: 29391539 [TBL] [Abstract][Full Text] [Related]
50. Iron metabolism in hepcidin1 knockout mice in response to phenylhydrazine-induced hemolysis. Masaratana P; Latunde-Dada GO; Patel N; Simpson RJ; Vaulont S; McKie AT Blood Cells Mol Dis; 2012 Aug; 49(2):85-91. PubMed ID: 22609087 [TBL] [Abstract][Full Text] [Related]
51. Interleukin-1 receptor antagonist gene polymorphism and hepcidin in rheumatoid arthritis: Correlations with clinical and laboratory indices of disease activity. Swellam M; Gabal KM; Youssef SS IUBMB Life; 2013 Oct; 65(10):883-8. PubMed ID: 24014495 [TBL] [Abstract][Full Text] [Related]
52. Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells. Noguchi-Sasaki M; Sasaki Y; Shimonaka Y; Mori K; Fujimoto-Ouchi K BMC Cancer; 2016 Apr; 16():270. PubMed ID: 27068103 [TBL] [Abstract][Full Text] [Related]
53. Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis. Bloomer SA; Olivier AK; Bergmann OM; Mathahs MM; Broadhurst KA; Hicsasmaz H; Brown KE Cell Biochem Funct; 2016 Dec; 34(8):628-639. PubMed ID: 27935134 [TBL] [Abstract][Full Text] [Related]
55. Benzopyrimidodiazepinone inhibitors of TNK2. Groendyke BJ; Powell CE; Feru F; Gero TW; Li Z; Szabo H; Pang K; Feutrill J; Chen B; Li B; Gray NS; Scott DA Bioorg Med Chem Lett; 2020 Feb; 30(4):126948. PubMed ID: 31928839 [TBL] [Abstract][Full Text] [Related]
56. The design, synthesis and evaluation of 2-aminobenzoxazole analogues as potent and orally efficacious ChemR23 inhibitors. Imaizumi T; Otsubo S; Komai M; Takada H; Maemoto M; Kobayashi A; Otsubo N Bioorg Med Chem; 2020 Sep; 28(17):115622. PubMed ID: 32773087 [TBL] [Abstract][Full Text] [Related]
57. Mouse models of anemia of cancer. Kim A; Rivera S; Shprung D; Limbrick D; Gabayan V; Nemeth E; Ganz T PLoS One; 2014; 9(3):e93283. PubMed ID: 24681760 [TBL] [Abstract][Full Text] [Related]
58. Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986). Doyle K; Lönn H; Käck H; Van de Poël A; Swallow S; Gardiner P; Connolly S; Root J; Wikell C; Dahl G; Stenvall K; Johannesson P J Med Chem; 2016 Oct; 59(20):9457-9472. PubMed ID: 27690432 [TBL] [Abstract][Full Text] [Related]
59. BuMPing iron with modified heparins. Babitt JL; Lin HY Blood; 2014 Mar; 123(10):1440-1. PubMed ID: 24627550 [TBL] [Abstract][Full Text] [Related]